Summary

Anaphylaxis Market – Scope of Report
TMR’s report on the global anaphylaxis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global anaphylaxis market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global anaphylaxis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the anaphylaxis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global anaphylaxis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global anaphylaxis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global anaphylaxis market.

The report delves into the competitive landscape of the global anaphylaxis market. Key players operating in the global anaphylaxis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global anaphylaxis market profiled in this report.

Key Questions Answered in global anaphylaxis Market Report
• What is the sales/revenue generated by anaphylaxis across all regions during the forecast period?
• What are the opportunities in the global anaphylaxis market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Anaphylaxis Market – Research Objectives and Research Approach
The comprehensive report on the global anaphylaxis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global anaphylaxis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global anaphylaxis market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Anaphylaxis Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anaphylaxis Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Healthcare Expenditure across Key Regions / Countries
5.2. Technological Advancements in Anaphylaxis Management
5.3. Epidemiology of Anaphylaxis across Key Regions / Countries
5.4. Regulatory Scenario across Key Regions / Countries
5.5. PORTER’s Five Forces Analysis
5.6. PESTEL Analysis
5.7. Value Chain Analysis
5.8. Key Purchase Metrics for End-users
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
5.11. Benchmarking of Products Offered by the Leading Competitors
6. Global Anaphylaxis Market Analysis and Forecasts, By Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Drug Class, 2020-2035
6.3.1. Epinephrine
6.3.2. Antihistamines
6.3.3. Others
6.4. Market Attractiveness By Drug Class
7. Global Anaphylaxis Market Analysis and Forecasts, By Dosage Form
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Dosage Form, 2020-2035
7.3.1. Injectables
7.3.2. Tablets / Capsules
7.3.3. Others
7.4. Market Attractiveness By Dosage Form
8. Global Anaphylaxis Market Analysis and Forecasts, By Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Route of Administration, 2020-2035
8.3.1. Intramuscular Injection
8.3.2. Subcutaneous Injection
8.3.3. Oral
8.3.4. Others
8.4. Market Attractiveness By Route of Administration
9. Global Anaphylaxis Market Analysis and Forecasts, By Drug Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Drug Type, 2020-2035
9.3.1. Branded
9.3.2. Generic
9.4. Market Attractiveness By Drug Type
10. Global Anaphylaxis Market Analysis and Forecasts, By Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Distribution Channel, 2020-2035
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness By Distribution Channel
11. Global Anaphylaxis Market Analysis and Forecasts, By Region
11.1. Key Findings
11.2. Market Value Forecast By Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness By Region
12. North America Anaphylaxis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Drug Class, 2020-2035
12.2.1. Epinephrine
12.2.2. Antihistamines
12.2.3. Others
12.3. Market Value Forecast By Dosage Form, 2020-2035
12.3.1. Injectables
12.3.2. Tablets / Capsules
12.3.3. Others
12.4. Market Value Forecast By Route of Administration, 2020-2035
12.4.1. Intramuscular Injection
12.4.2. Subcutaneous Injection
12.4.3. Oral
12.4.4. Others
12.5. Market Value Forecast By Drug Type, 2020-2035
12.5.1. Branded
12.5.2. Generic
12.6. Market Value Forecast By Distribution Channel, 2020-2035
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.7. Market Value Forecast By Country, 2020-2035
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Drug Class
12.8.2. By Dosage Form
12.8.3. By Route of Administration
12.8.4. By Drug Type
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Anaphylaxis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Drug Class, 2020-2035
13.2.1. Epinephrine
13.2.2. Antihistamines
13.2.3. Others
13.3. Market Value Forecast By Dosage Form, 2020-2035
13.3.1. Injectables
13.3.2. Tablets / Capsules
13.3.3. Others
13.4. Market Value Forecast By Route of Administration, 2020-2035
13.4.1. Intramuscular Injection
13.4.2. Subcutaneous Injection
13.4.3. Oral
13.4.4. Others
13.5. Market Value Forecast By Drug Type, 2020-2035
13.5.1. Branded
13.5.2. Generic
13.6. Market Value Forecast By Distribution Channel, 2020-2035
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.7. Market Value Forecast By Country / Sub-region, 2020-2035
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Drug Class
13.8.2. By Dosage Form
13.8.3. By Route of Administration
13.8.4. By Drug Type
13.8.5. By Distribution Channel
13.8.6. By Country / Sub-region

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 01: Global Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 02: Global Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 03: Global Anaphylaxis Market Revenue (US$ Bn), by Epinephrine, 2020-2035
Figure 04: Global Anaphylaxis Market Revenue (US$ Bn), by Antihistamines, 2020-2035
Figure 05: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
Figure 06: Global Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 07: Global Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 08: Global Anaphylaxis Market Revenue (US$ Bn), by Injectables, 2020-2035
Figure 09: Global Anaphylaxis Market Revenue (US$ Bn), by Tablets / Capsules, 2020-2035
Figure 10: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
Figure 11: Global Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 12: Global Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 13: Global Anaphylaxis Market Revenue (US$ Bn), by Intramuscular Injection, 2020-2035
Figure 14: Global Anaphylaxis Market Revenue (US$ Bn), by Subcutaneous Injection, 2020-2035
Figure 15: Global Anaphylaxis Market Revenue (US$ Bn), by Oral, 2020-2035
Figure 16: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
Figure 17: Global Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 18: Global Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 19: Global Anaphylaxis Market Revenue (US$ Bn), by Branded, 2020-2035
Figure 20: Global Anaphylaxis Market Revenue (US$ Bn), by Generic, 2020-2035
Figure 21: Global Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 22: Global Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
Figure 23: Global Anaphylaxis Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
Figure 24: Global Anaphylaxis Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
Figure 25: Global Anaphylaxis Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
Figure 26: Global Anaphylaxis Market Value Share Analysis, By Region, 2024 and 2035
Figure 27: Global Anaphylaxis Market Attractiveness Analysis, By Region, 2025-2035
Figure 28: North America - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
Figure 29: North America - Anaphylaxis Market Value Share Analysis, by Country, 2024 and 2035
Figure 30: North America - Anaphylaxis Market Attractiveness Analysis, by Country, 2025-2035
Figure 31: North America - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 32: North America - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 33: North America - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 34: North America - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 35: North America - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 36: North America - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 37: North America - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 38: North America - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 39: North America - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 40: North America - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
Figure 41: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
Figure 42: Europe - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 43: Europe - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 44: Europe - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 45: Europe - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 46: Europe - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 47: Europe - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 48: Europe - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 49: Europe - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 50: Europe - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 51: Europe - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 52: Europe - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 53: Europe - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
Figure 54: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
Figure 55: Asia Pacific - Anaphylaxis Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 56: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 57: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 58: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 59: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 60: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 61: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 62: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 63: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 64: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 65: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 66: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
Figure 67: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
Figure 68: Latin America - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 69: Latin America - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 70: Latin America - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 71: Latin America - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 72: Latin America - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 73: Latin America - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 74: Latin America - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 75: Latin America - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 76: Latin America - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 77: Latin America - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 78: Latin America - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 79: Latin America - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
Figure 80: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
Figure 81: Middle East & Africa - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 82: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 83: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
Figure 84: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
Figure 85: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
Figure 86: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
Figure 87: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 88: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
Figure 89: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 90: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
Figure 91: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 92: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035